Please select the option that best describes you:
How do you manage anticoagulation/antiplatelet therapies with strong indications for uninterrupted therapy in setting of urgent procedures?
For example, anticoagulation for recent, significant PE or dual antiplatelet therapy for recent MI, but requiring urgent procedures such as biopsy of a potential new malignancy or procedural management of a malignancy.
What are some guiding principles that you use to direct care?
Answer from: at Community Practice
If anticoagulation is absolutely contraindicated because of the bleeding risk of the procedure, then "bridging" will usually make the most sense, most of the time, with low molecular weight heparin such as enoxaparin.
If dual antiplatelet agents are contraindicated, particularly in the first month ...
Sign in or Register to read more